NSEDCP
NJ State Employees Deferred Compensation Plan’s Acadia Pharmaceuticals ACAD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $367K | Hold |
17,000
| – | – | 0.04% | 324 |
|
2025
Q1 | $282K | Hold |
17,000
| – | – | 0.04% | 362 |
|
2024
Q4 | $312K | Hold |
17,000
| – | – | 0.04% | 359 |
|
2024
Q3 | $261K | Hold |
17,000
| – | – | 0.03% | 395 |
|
2024
Q2 | $276K | Hold |
17,000
| – | – | 0.03% | 380 |
|
2024
Q1 | $314K | Hold |
17,000
| – | – | 0.04% | 367 |
|
2023
Q4 | $532K | Hold |
17,000
| – | – | 0.07% | 271 |
|
2023
Q3 | $354K | Hold |
17,000
| – | – | 0.05% | 328 |
|
2023
Q2 | $407K | Hold |
17,000
| – | – | 0.06% | 317 |
|
2023
Q1 | $320K | Hold |
17,000
| – | – | 0.05% | 363 |
|
2022
Q4 | $271K | Hold |
17,000
| – | – | 0.04% | 380 |
|
2022
Q3 | $278K | Hold |
17,000
| – | – | 0.05% | 368 |
|
2022
Q2 | $240K | Hold |
17,000
| – | – | 0.04% | 397 |
|
2022
Q1 | $412K | Hold |
17,000
| – | – | 0.06% | 334 |
|
2021
Q4 | $397K | Hold |
17,000
| – | – | 0.05% | 349 |
|
2021
Q3 | $282K | Hold |
17,000
| – | – | 0.04% | 412 |
|
2021
Q2 | $415K | Hold |
17,000
| – | – | 0.06% | 337 |
|
2021
Q1 | $439K | Hold |
17,000
| – | – | 0.06% | 329 |
|
2020
Q4 | $909K | Hold |
17,000
| – | – | 0.14% | 149 |
|
2020
Q3 | $701K | Hold |
17,000
| – | – | 0.13% | 166 |
|
2020
Q2 | $824K | Hold |
17,000
| – | – | 0.15% | 132 |
|
2020
Q1 | $718K | Hold |
17,000
| – | – | 0.16% | 127 |
|
2019
Q4 | $727K | Hold |
17,000
| – | – | 0.12% | 169 |
|
2019
Q3 | $612K | Hold |
17,000
| – | – | 0.11% | 185 |
|
2019
Q2 | $454K | Sell |
17,000
-4,000
| -19% | -$107K | 0.08% | 300 |
|
2019
Q1 | $564K | Hold |
21,000
| – | – | 0.1% | 218 |
|
2018
Q4 | $340K | Sell |
21,000
-11,000
| -34% | -$178K | 0.07% | 339 |
|
2018
Q3 | $664K | Sell |
32,000
-8,000
| -20% | -$166K | 0.11% | 214 |
|
2018
Q2 | $611K | Buy |
+40,000
| New | +$611K | 0.11% | 247 |
|